ZimVie Inc.

ZIMV

US98888T1079

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-23 EDT			5-day change	1st Jan Change
16.72 ^USD	-4.02%		+0.24%	-5.80%

05-17	North American Morning Briefing : The "Everything -2-	DJ
05-16	Needham Upgrades ZimVie to Buy From Hold, Sets Price Target at $20, Sees Company 'Well Positioned for Durable Margin Improvement'	MT

ZimVie Inc. Provides Earnings Guidance for the Full Year 2024 Ending December 31, 2024

May 08, 2024 at 04:05 pm

ZimVie Inc. provided earnings guidance for the full year ending December 31, 2024. For the year, the company expects net sales to be in the range of $450 Million to $460 Million.

Latest news about ZimVie Inc.

North American Morning Briefing : The "Everything -2-	05-17	DJ
Needham Upgrades ZimVie to Buy From Hold, Sets Price Target at $20, Sees Company 'Well Positioned for Durable Margin Improvement'	05-16	MT
Transcript : ZimVie Inc., Q1 2024 Earnings Call, May 08, 2024	05-08
Earnings Flash (ZIMV) ZIMVIE Reports Q1 EPS $0.08	05-08	MT
Earnings Flash (ZIMV) ZIMVIE Reports Q1 Revenue $118.2M, vs. Street Est of $116.4M	05-08	MT
(ZIMV) ZIMVIE Expects Fiscal Year 2024 EPS Range $0.55 - $0.70	05-08	MT
ZimVie Inc. Provides Earnings Guidance for the Full Year 2024 Ending December 31, 2024	05-08	CI
ZimVie Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
H.I.G. Capital, LLC completed the acquisition of Zimmer Biomet Spine, Inc. from ZimVie Inc..	03-31	CI
ZimVie Inc.(NasdaqGS:ZIMV) added to S&P Healthcare Equipment Select Industry Index	03-17	CI
Barclays Adjusts Price Target on ZimVie to $16 From $13, Maintains Underweight Rating	03-05	MT
Transcript : ZimVie Inc., Q4 2023 Earnings Call, Feb 28, 2024	02-28
ZimVie Inc. Provides Earnings Guidance for First Quarter and Raises Earnings Guidance for the Full Year 2024	02-28	CI
ZimVie Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-28	CI
(ZIMV) ZIMVIE Expects Q1 Revenue Range $115M - $118M	02-28	MT
Earnings Flash (ZIMV) ZIMVIE Reports Q4 Revenue $113.1M	02-28	MT
Earnings Flash (ZIMV) ZIMVIE Reports Q4 EPS $0.11, vs. Street Est of $0.13	02-28	MT
ZimVie Inc. Announces Launch of Next-Generation TSX®? Implant in Japan	02-07	CI
Top Midday Gainers	12-18	MT
ZimVie to Sell Spine Business to H.I.G. Capital for $375 Million; Shares Rise	12-18	MT
H.I.G. Capital, LLC entered into an Equity Purchase Agreement to acquire Zimmer Biomet Spine, Inc. from ZimVie Inc. for approximately $380 million.	12-17	CI
ZimVie Inc. Announces Compatibility Between Its Vital Spinal Fixation System and Brainlab Spine & Trauma Navigation	12-12	CI
Needham Starts ZimVie With Hold Rating	11-16	MT
Top Premarket Decliners	11-02	MT
Transcript : ZimVie Inc., Q3 2023 Earnings Call, Nov 01, 2023	11-01

ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-30 - Stifel Jaws & Paws Conference

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

17.42 USD

Average target price

18 USD

Spread / Average Target

+3.33%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
ZIMVIE INC.	-5.80%	475M
SHOCKWAVE MEDICAL, INC.	+75.33%	12.54B
PENUMBRA, INC.	-24.19%	7.71B
MASIMO CORPORATION	+6.43%	6.72B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+13.59%	5.38B
APT MEDICAL INC.	+34.82%	4.89B
GETINGE AB	-15.69%	4.71B
ASAHI INTECC CO., LTD.	-25.08%	3.75B
INARI MEDICAL, INC.	-26.93%	2.77B
NOVOCURE LIMITED	+49.43%	2.55B

Medical Equipment

ZimVie Inc.

Equities

ZIMV

US98888T1079

Medical Equipment, Supplies & Distribution

ZimVie Inc. Provides Earnings Guidance for the Full Year 2024 Ending December 31, 2024

Latest news about ZimVie Inc.

Chart ZimVie Inc.

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Equipment